IP Verse

Enteric Film Coating Compositions, Method Of Coating, And Coated Forms - EP3236954

The patent EP3236954 was granted to Dupont Nutrition USA on Sep 4, 2024. The application was originally filed on Dec 22, 2015 under application number EP15874302A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3236954

DUPONT NUTRITION USA
Application Number
EP15874302A
Filing Date
Dec 22, 2015
Status
Patent Maintained As Amended
Aug 2, 2024
Grant Date
Sep 4, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ROQUETTE FRERESDec 23, 2022PLASSERAUDWITHDRAWN

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTUS2004062855
INTERNATIONAL-SEARCH-REPORTUS2005106233
INTERNATIONAL-SEARCH-REPORTUS2011059165
INTERNATIONAL-SEARCH-REPORTUS5733575
OPPOSITIONFR2934467
OPPOSITIONWO2012022498
OPPOSITIONWO2012131476
OPPOSITIONWO2014136857
SEARCHWO2012022498
SEARCHWO2012131476
SEARCHWO2014136857

Non-Patent Literature (NPL) Citations (8) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- VESKI P ET AL, "SODIUM ALGINATES AS DILUENTS IN HARD GELATIN CAPSULES CONTAINING IBUPROFEN AS A MODEL DRUG", PHARMAZIE, GOVI VERLAG PHARMAZEUTISCHER VERLAG GMBH, DE, (19931001), vol. 48, no. 10, ISSN 0031-7144, pages 757 - 760, XP000398955-
OPPOSITION- EFA, April 29, 5, Rina Chokshi, FMC.pdf-
OPPOSITION- MIKINORI U. et al., "Biological Activities of Alginate", Advances in Food Nutrition Research, (20140000), vol. 72, pages 95 - 112-
OPPOSITION- MIKINORI U. et al., "Biological Activities of Alginate", Advances in Food Nutrition Research, (20140000), vol. 72, pages 95 - 112, XP093012152-
OPPOSITION- VELINE VALERIA LIEW et al., "Evaluation of sodium alginate as drug release modifier in matrix tablets", International Journal of Pharmaceutics, (20060000), vol. 309, doi:10.1016/j.ijpharm.2005.10.040, pages 25 - 37-
OPPOSITION- VESKI P. et al., "Sodium Alginates as diluents in hard gelatin capsules containing ibuprofen as a model drug", Pharmazie, (19930000), vol. 48, no. 10, pages 757 - 760-
OPPOSITION- VESKI P. et al., "Sodium Alginates as diluents in hard gelatin capsules containing ibuprofen as a model drug", Pharmazie, (19930000), vol. 48, no. 10, pages 757 - 760, XP000398955-
OPPOSITION- VELINE VALERIA LIEW et al., "Evaluation of sodium alginate as drug release modifier in matrix tablets", International Journal of Pharmaceutics, (20060000), vol. 309, doi:10.1016/j.ijpharm.2005.10.040, pages 25 - 37, XP055564045

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents